Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 1, 2020
The Source Summer 2020
Magazine of the plasma protein therapeutics industry - Summer 2020
All
The Source Magazine
https://drive.google.com/file/d/1nLFNgHSD4LcL0DLgbtbKufxP4qs0VUhW/view?usp=sharing
Jun 1, 2020
The Source Summer 2020
Magazine of the plasma protein therapeutics industry - Summer 2020
All
The Source Magazine
https://drive.google.com/file/d/1nLFNgHSD4LcL0DLgbtbKufxP4qs0VUhW/view?usp=sharing
May 1, 2020
Physicians in European Plasma Collection Centers
Many European countries have regulatory systems, which require the presence of a physician at all times in plasma collection centers.
All
Advocacy
https://plasmaprotein.sharepoint.com/:b:/s/EU/EUlhH2KT7FtCh5puxKTq7oQB2LUBty3vutdZqorv3FK8_w?e=lQ7y56
May 1, 2020
Physicians in European Plasma Collection Centers
Many European countries have regulatory systems, which require the presence of a physician at all times in plasma collection centers.
All
Advocacy
https://plasmaprotein.sharepoint.com/:b:/s/EU/EUlhH2KT7FtCh5puxKTq7oQB2LUBty3vutdZqorv3FK8_w?e=lQ7y56
Apr 3, 2020
PPTA Statement on FDA Guidance Documents
PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them.
All
PPTA statements
Apr 3, 2020
PPTA Statement on FDA Guidance Documents
PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them.
All
PPTA statements
Apr 3, 2020
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
PPTA considers that the SARS-CoV-2 outbreak is not a concern for the safety of plasma protein therapies manufactured by PPTA member companies. The assessment is shared by notable international and national public health bodies, including the WHO, the ECDC, and others.
All
PPTA statements
Apr 3, 2020
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
PPTA considers that the SARS-CoV-2 outbreak is not a concern for the safety of plasma protein therapies manufactured by PPTA member companies. The assessment is shared by notable international and national public health bodies, including the WHO, the ECDC, and others.
All
PPTA statements
Aucun résultat n'a été trouvé